Flo Health, the leading women’s health app globally, has secured over $200 million in a Series C funding round from General Atlantic, a prominent global growth investor. This investment elevates Flo’s valuation to over $1 billion, marking it as the first purely digital consumer women’s health app to achieve unicorn status. The app supports nearly 70 million monthly active users and offers a comprehensive platform for menstrual, reproductive, and menopause health. With over 120 medical experts on board, Flo provides tailored health insights, symptom tracking, and community support. The app has also introduced features like ‘Flo for Partners’ and the award-winning ‘Anonymous Mode,’ which is recognized for its commitment to privacy and sensitive health information.
The partnership with General Atlantic positions Flo for further growth, focusing on expanding into new user segments, enhancing technology-driven insights, and increasing its research and development capabilities. Flo aims to reach one billion women globally through its pro-social program, which offers free access to Flo Premium in underserved regions. General Atlantic's expertise in scaling technology and subscription-based companies will support Flo’s mission to revolutionize women's health and promote health literacy worldwide.
